September 28, 2022 by Jeffrey Woldt
Chain Drug Review/MMR Video Forum, Scott Emerson, The Emerson Group, Video Forum
Featured Articles, Leading Headlines, Videos
Scott Emerson, founder and president of the Emerson Group, an organization dedicated to helping small and mid-size brands compete in a marketplace dominated by large CPG suppliers, tells Video Forum about plans for the company’s upcoming Industry Day. In addition, he shares his views about how consumers and retailers have adapted to the turmoil of
June 3, 2022 by Chain Drug Review
The Emerson Group
Business, Leading Headlines, Supplier News
WAYNE, Pa. — The Emerson Group announced that it is opening early registration for its annual Industry Day event being held Wednesday, October 12th. “This is a “can’t miss” event. We will once again be broadcasting the live event from the Pando Studio just outside Philadelphia, Pa. and bringing the show to you virtually. Just
February 1, 2022 by Chain Drug Review
Bourne Partners, Hildred Capital Management, The Emerson Group
Leading Headlines, Supplier News
WAYNE, Pa. – Health care private equity firms Hildred Capital Management, LLC and Bourne Partners Strategic Capital, together with The Emerson Group, launch Carlin Consumer Health to establish a preeminent consumer health business and to acquire leading over-the-counter (O-T-C) brands. Carlin will be uniquely positioned to acquire and commercialize well-established brands as well as support
January 24, 2022 by Chain Drug Review
The Emerson Group
Leading Headlines, Supplier News
WAYNE, Pa. — The Emerson Group has announced a number of changes and realignments to their organization that will allow the company to focus their personnel resources and further build out capabilities to better serve their brands and retailers. Jen Beatty, East Area Lead, will pick up responsibility for both Inside Sales and Drug Wholesale retail,
October 7, 2021 by Chain Drug Review
Ed Morgan, Emerson Industry Day 2021, NACDS, The Emerson Group
Business, Featured Articles, Leading Headlines, Retail News, Supplier News
PHILADELPHIA — While the COVID-19 pandemic is by no means a thing of the past, its profound impact over the last 18 months on so many different aspects of life has naturally raised the question of what lies ahead, what is next — for individuals, for society, for industry. For the retail industry as a
November 30, 2020 by Chain Drug Review
Emerson Naturals, Kimberly Weld, The Emerson Group
Leading Headlines, Supplier News
WAYNE, Pa. — A broader consumer interest in health and wellness continues to drive an acceleration in the demand for natural products. As shopper trips continue to shift and be more selective natural brands must have an omnichannel presence to meet the consumer’s needs along their health and wellness journey. In light of that, The
October 8, 2020 by Chain Drug Review
“Creating the Future of Retail…Together.”, Chain Drug Review, Mass Market Retailers and NACDS. The event carried the title, NACDS, NACDS president and chief executive officer Steven Anderson, The Emerson Group, WSL Strategic Marketing
Leading Headlines, Pharmacy
ARLINGTON, Va. — NACDS president and CEO Steven Anderson delivered remarks this week intended to serve as the “rallying cry that this industry deserves.” The remarks served as a salute to the teams of NACDS-member pharmacies and suppliers who have served heroically during the COVID-19 pandemic, and as a call to action to government to
October 8, 2020 by Chain Drug Review
Alex Gourlay, Ed Morgan, Jen Beatty, Larry Merlo, Scott Emerson, Steven Anderson, The Emerson Group
Business, Featured Articles, Leading Headlines, Supplier News
NEW YORK — The COVID-19 pandemic has left few major business sectors untouched, and retail — as well as the supplier community that serves it — is adapting to a landscape transformed by profound changes in consumer behavior and priorities. To help the industry navigate these uncharted waters, Chain Drug Review and Mass Market Retailers
July 24, 2020 by Chain Drug Review
Oystershell Consumer Health, The Emerson Group, The RID brand of Lice Protection
Leading Headlines, Supplier News
WAYNE, Pa. — The Emerson Group has added Oystershell Consumer Health, makers of the RID brand of lice treatment to its family of products. Emerson CPG Equity Management will be responsible for brand management, creative execution, and day-to-day operations of the RID brand. The Emerson Group will manage all sales activity for the RID brand
June 19, 2020 by Chain Drug Review
Abacus Health Products, Charlotte's Web, Ed Morgan, The Emerson Group
Leading Headlines, Supplier News
WAYNE, Pa. — The Emerson Group announced that starting in July 2020 it will welcome Charlotte’s Web to its family and portfolio of CBD Brands. Charlotte’s Web is the market leader in the production and distribution of innovative hemp-derived cannabidiol wellness products. In addition, the company is a market leader in the CBD space on
March 5, 2020 by Chain Drug Review
Bourne Partners, Daybreak Consumer Care, The Emerson Group
Business, Leading Headlines, Supplier News
WAYNE, Pa. — Bourne Partners, a health care-focused private equity investor and investment bank, is investing in a joint venture with The Emerson Group, an international consumer products equity organization, to build a global consumer health and wellness platform focused on acquiring and commercializing branded, over- the-counter (O-T-C) medications and personal care brands. This new
September 5, 2019 by Chain Drug Review
CBD, CBDfx, Jameson Rodgers, Natalie Hodgman, The Emerson Group
Leading Headlines, Supplier News
CHATSWORTH, Calif. — CBDfx, the third-largest privately held hemp-derived CBD company according to the Brightfield Group, has announced a new partnership with The Emerson Group which will allow retailers and their customers entry into the flourishing CBD industry. A market leader in hemp-derived CBD, CBDfx is known for their rigorous quality standards and trendsetting product
July 22, 2019 by Chain Drug Review
Bayer, Dr. Scholl's, The Emerson Group, Yellow Wood Partners
Leading Headlines, Supplier News
WHIPPANY, N.J.— German pharmaceutical company Bayer AG said Monday U.S. investment firm Yellow Wood Partners will acquire its Dr. Scholl’s foot care business for $585 million. Bayer reported that the sale will enable it to “focus on building its core over-the-counter brands.” It said that Yellow Wood Partners, based in Boston, will create a stand-alone
July 11, 2019 by Chain Drug Review
Mark Land, Scot Emerson, The American Association of Homeopathic Pharmacists (AAHP), The Emerson Group, Wegmans
Leading Headlines, Slideshows
BALTIMORE — The American Association of Homeopathic Pharmacists (AAHP) convened its inaugural industry summit here last month to celebrate recent gains in the marketplace while assessing the challenges suppliers face in engaging with regulators and earning consumers’ trust. “We have a responsibility to produce products of the highest quality so that consumers and families across